Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
Aijia Ma, Jiangli Cheng, Jing Yang, Meiling Dong, Xuelian Liao, Yan Kang
Abstract
TRIAL REGISTRATION: ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered.
Topics & Concepts
MedicineARDSCoronavirus disease 2019 (COVID-19)Biomarker2019-20 coronavirus outbreakNeutrophil to lymphocyte ratioSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicIntensive care medicineLymphocyteEmergency medicineInternal medicineVirologyLungOutbreakDiseaseInfectious disease (medical specialty)ChemistryBiochemistryRespiratory Support and MechanismsCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19